Source-based interaction record

Laroxyl 10 mg + Lyrica 150 mg

Laroxyl 10 mg + Lyrica 150 mg: published drug interaction record, medicine facts and reference links. Generic / active ingredient: Amitriptilin + Pregabalin.

Free preview

Essential record information

Public access

Free record overview for Laroxyl 10 mg + Lyrica 150 mg. Review the medicine identities and available reference links below; detailed interaction information is in the access section.

Laroxyl 10 mg

Active ingredient / generic name: Amitriptilin
ATC code: N06AA09

Lyrica 150 mg

Active ingredient / generic name: Pregabalin
ATC code: N03AX16

Record type: Published interaction record

Record sources

Original interaction source (recorded provenance) (opens in a new tab)

Source checked: 2026-10-15

A source check is not an independent clinical review.

Access to this record

Free preview: Medicine identities, available source links and, where available, selected low-level related interaction records.
Paid details: The selected pair’s available detailed interaction explanation, mechanism and clinical context can be read with single-page access or an eligible membership page allowance.

A single-page purchase unlocks this resource only. Membership provides the page allowance shown in your plan; it does not unlock every related record automatically.

This page only: 6.00 USD One-time payment
Monthly membership: 40.00 USD / month · starting price

A free account with a verified email address is required before checkout. Monthly membership renews automatically with no trial period. Taxes and the final total appear in checkout.

Examples selected from real records

Selected free interaction examples

Free

These examples concern other medicine pairs involving the medicines above. They do not assess the main pair on this page.

Published related records: 294. The selection below does not represent the complete list.

Informational

Lyrica 150 mg + Rupafin 10 mg Tablet

Recorded classification; this selection is not a full list or a conclusion that use is safe.

www.medicines.org.uk Source checked: 2026-10-15

View record

Examples selected from real records

Published records

The identity and source of these published related records are shown below. Clinical details are displayed according to your access to each record.

Details require access

Lyrica 150 mg + Tapentadol

The interaction assessment and details for this pair are in that page’s access section.

dailymed.nlm.nih.gov Source checked: 2026-11-05

Details and access

Details require access

Lyrica 150 mg + Metaxalone

The interaction assessment and details for this pair are in that page’s access section.

dailymed.nlm.nih.gov Source checked: 2026-11-05

Details and access

Important information and detailed context

Unlock important interaction details

The basic information is available above. Details such as explanations of moderate or severe interaction records, mechanisms and clinical context are available through paid access to the relevant record or your membership allowance.

The related record group also includes interactions classified as moderate or severe. Each record’s access right applies to its own details.

Interaction level and explanation
Interaction mechanism
Clinical context and precautions

This page only

6.00 USDOne-time payment

Permanent access to this record and its available language versions. No subscription required.

Buy access to this page

Monthly membership

40.00 USD/ month · starting price

30 different records per billing period. Reading a record again in the same period does not use another page allowance.

Explore memberships

Monthly memberships renew automatically; there is no trial period. Taxes and the final total appear in checkout.

A verified account is required. Turkish and English versions of the same resource share one access right.

Check medicine interactions

Results show the recorded information for the two medicines. A missing record does not mean there is no interaction.

Results open in English when available, otherwise in Turkish. Each record keeps its own access requirements.

This information is not personal treatment advice. Discuss treatment decisions with your doctor or pharmacist.